ArticleMolecules (Basel, Switzerland)2023
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of
Satyamvada Maurya, Amita Jain, Md Tabish Rehman, Ali Hakamy, Farkad Bantun, Mohamed F AlAjmi, Vineeta Singh, Aafreen Zehra, Feroz Khan, Shafiul Haque and 1 more
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Satyamvada MauryaDepartment of Biotechnology, Institute of Engineering & Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow 226021, India.
Amita JainDepartment of Microbiology, King George Medical University, Lucknow 226003, India.
Md Tabish RehmanDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-2341-900X Ali HakamyRespiratory Therapy Department, Faculty of Applied Medical Sciences, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0000-0001-9318-1784 Farkad BantunDepartment of Microbiology, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-7851-6977 Mohamed F AlAjmiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Vineeta SinghDepartment of Biotechnology, Institute of Engineering & Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow 226021, India.
Aafreen ZehraTechnology Dissemination and Computational Biology Unit, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India.
Feroz KhanTechnology Dissemination and Computational Biology Unit, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow 226015, India.ORCID 0000-0002-2704-5925 Shafiul HaqueResearch & Scientific Studies Unit, College of Nursing & Allied Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.ORCID 0000-0002-2989-121X Bhartendu Nath MishraDepartment of Biotechnology, Institute of Engineering & Technology, Dr. A.P.J. Abdul Kalam Technical University, Lucknow 226021, India.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
The emergence of multi-drug-resistant
Indexed as
Mycobacterium tuberculosisTuberculosisHumansMolecular Dynamics SimulationRibonucleasesRifampinSensitivity and SpecificityRibonucleasesRifampinADMETmolecular dockingMycobacterium tuberculosisradius of gyrationroot mean square deviationroot mean square fluctuationtuberculosis
Identifiers
PMID36838640
PMCPMC9968056
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390